rAdp53

Shenzhen SiBiono GeneTech Co.,Ltd · Phase 2 active Small molecule

At a glance

Generic name	rAdp53
Also known as	recombinant adenoviral p53 human gene
Sponsor	Shenzhen SiBiono GeneTech Co.,Ltd
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

rAdp53 CI brief — competitive landscape report
rAdp53 updates RSS · CI watch RSS
Shenzhen SiBiono GeneTech Co.,Ltd portfolio CI